Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04154930 · ClinicalTrials.gov registry record · NA
Restylane-L for Correction of Infraorbital Hollows
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 333
- Enrollment target
NCT04154930 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 333 participants.
The verdict
NCT04154930, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 333 participants
- Enrollment target
Study Summary
This is a prospective, randomized, evaluator-blinded, no-treatment controlled, parallel group, multi-center US study to evaluate the safety and effectiveness of Restylane-L® for correction of Infraorbital Hollows.
Interventions
- DEVICE Restylane-L®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2022-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04154930
The ClinicalTrials.gov registry entry for NCT04154930 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane-L® is the first listed.
NCT04154930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04154930 about?
NCT04154930 is a clinical study titled "Restylane-L for Correction of Infraorbital Hollows". This is a prospective, randomized, evaluator-blinded, no-treatment controlled, parallel group, multi-center US study to evaluate the safety and effectiveness of Restylane-L® for correction of Infraorbital Hollows.
What is the current status of trial NCT04154930?
This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2019-11-11. Estimated completion is 2022-04-06.
What interventions are being tested in trial NCT04154930?
The interventions under investigation include: Restylane-L® (DEVICE).
Who is sponsoring clinical trial NCT04154930?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.